# Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

> **NCT02090933** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 25 (actual)

## Conditions studied

- No Evidence of Disease

## Interventions

- **DRUG:** Celecoxib
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** UV Light Therapy

## Key facts

- **NCT ID:** NCT02090933
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02090933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02090933, "Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02090933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*